{
    "Trade/Device Name(s)": [
        "CEDIA Buprenorphine II Assay",
        "CEDIA Buprenorphine II Calibrators",
        "CEDIA Negative Calibrator II",
        "CEDIA Buprenorphine II Control Set"
    ],
    "Submitter Information": "Microgenics Corporation",
    "510(k) Number": "K163101",
    "Predicate Device Reference 510(k) Number(s)": [
        "K040316"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DJG",
        "DLJ",
        "LAS"
    ],
    "Summary Letter Date": "March 17, 2017",
    "Summary Letter Received Date": "March 20, 2017",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3650",
        "21 CFR 862.3200",
        "21 CFR 862.3280"
    ],
    "Regulation Name(s)": [
        "Opiate test system",
        "Clinical toxicology control material"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Buprenorphine",
        "Norbuprenorphine",
        "Buprenorphine-\u03b2-D-glucuronide",
        "Norbuprenorphine-\u03b2-D-glucuronide"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "clinical chemistry analyzers",
        "Beckman Coulter AU 680 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Homogeneous enzyme immunoassay",
        "Cloned Enzyme Donor Immunoassay (CEDIA)"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Microgenics CEDIA Buprenorphine II Assay, calibrators, and controls for qualitative and semi-quantitative detection of buprenorphine and metabolites in urine using enzyme immunoassay on clinical chemistry analyzers.",
    "Indications for Use Summary": "For qualitative and/or semi-quantitative detection of buprenorphine and its metabolites in human urine to screen for buprenorphine use; calibrators and controls for assay calibration and validation in clinical laboratories.",
    "fda_folder": "Toxicology"
}